ES2183810T3 - 2,3,4,5-tetrahidro-1h-3-benzacepinas que tienen actividad antipsicotica, y sintesis de arilacetamidas - alfa-sustituidas. - Google Patents

2,3,4,5-tetrahidro-1h-3-benzacepinas que tienen actividad antipsicotica, y sintesis de arilacetamidas - alfa-sustituidas.

Info

Publication number
ES2183810T3
ES2183810T3 ES93906034T ES93906034T ES2183810T3 ES 2183810 T3 ES2183810 T3 ES 2183810T3 ES 93906034 T ES93906034 T ES 93906034T ES 93906034 T ES93906034 T ES 93906034T ES 2183810 T3 ES2183810 T3 ES 2183810T3
Authority
ES
Spain
Prior art keywords
alpha
pct
substituted
hydrogen atoms
cycloalkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93906034T
Other languages
English (en)
Inventor
Joel G Berger
Wei K Chang
Joseph A Kozlowski
Guowei Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2183810T3 publication Critical patent/ES2183810T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PRESENTA UN NUEVO PROCESO PARA LA PREPARACION DE ARILACETAMIDAS -SUSTITUIDAS EN EL CUAL EL SUSTITUYENTE ES UN GRUPO AROMATICO O UN GRUPO DE 1-ALQUENILO O DE 1-CICLOALQUENILO Y EN DONDE EL ATOMO DE NITROGENO NO SOPORTA ATOMOS DE HIDROGENO, EL PROCESO COMPRENDE LA REACCION DE UNA ARILACETAMIDA QUE TENGA UNO O DOS ATOMOS DE NITROGENO EN EL ATOMO DE CARBONO , EN EL QUE EL ATOMO DE NITROGENO NO SOPORTA ATOMOS DE HIDROGENO, CON UNA BASE FUERTE EN UN SOLVENTE ORGANICO APROTICO INERTE, SEGUIDA POR LA REACCION CON UN CATALIZADOR DE METAL DE TRANSICION DE VALENCIA 0 Y POSTERIORMENTE CON UN COMPUESTO DE LA FORMULA R4-X, EN DONDE R4 SE SELECCIONA ENTRE GRUPOS AROMATICOS, GRUPOS DE 1-ALQUENILO Y GRUPOS DE 1-CICLOALQUENILO Y X ES UN GRUPO SALIENTE PARTICULAR. LAS ARILACETAMIDAS -SUSTITUIDAS SON UTILES COMO PRODUCTOS INTERMEDIOS EN LA PREPARACION (MEDIANTE REDUCCION) DE ARILETILAMINOS -SUSTITUIDOS, POR EJEMPLO 2,3,4,5-TETRAHIDRO-1H-3BENZACEPINAS 1-SUSTITUIDAS, QUE TIENEN ACTIVIDAD FARMACOLOGICA. CIERTAS BENZACEPINAS EN LAS QUE EL SUSTITUYENTE 1 R4 ES 1-(1CICLOALQUENIL) SON NUEVAS.
ES93906034T 1992-02-25 1993-02-23 2,3,4,5-tetrahidro-1h-3-benzacepinas que tienen actividad antipsicotica, y sintesis de arilacetamidas - alfa-sustituidas. Expired - Lifetime ES2183810T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/841,603 US5241065A (en) 1992-02-25 1992-02-25 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity

Publications (1)

Publication Number Publication Date
ES2183810T3 true ES2183810T3 (es) 2003-04-01

Family

ID=25285279

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93906034T Expired - Lifetime ES2183810T3 (es) 1992-02-25 1993-02-23 2,3,4,5-tetrahidro-1h-3-benzacepinas que tienen actividad antipsicotica, y sintesis de arilacetamidas - alfa-sustituidas.

Country Status (12)

Country Link
US (2) US5241065A (es)
EP (1) EP0628030B1 (es)
JP (1) JPH07504196A (es)
AT (1) ATE229510T1 (es)
AU (1) AU3722193A (es)
CA (1) CA2130797C (es)
DE (1) DE69332559T2 (es)
ES (1) ES2183810T3 (es)
IL (1) IL104828A (es)
TW (1) TW241260B (es)
WO (1) WO1993016997A1 (es)
ZA (1) ZA931261B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US6867310B1 (en) 1997-11-20 2005-03-15 Massachusetts Institute Of Technology Arylation and vinylation of activated carbons
ES2209728T3 (es) * 1999-08-06 2004-07-01 F. Hoffmann-La Roche Ag Tetrahidro-benzo(d)azepinas y su uso como antagonistas de receptores de glutamato metabotropico.
EP1274744A2 (en) 2000-04-13 2003-01-15 E.I. DUPONT DE NEMOURS AND COMPANY, Legal Patent Records Center Polymer-supported synthesis of heteroatom bidentate ligands for catalysis
NZ540148A (en) 2002-12-20 2007-11-30 Glaxo Group Ltd Benzazepine derivatives for the treatment of neurological disorders
HUE028976T2 (en) 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
ZA200701232B (en) 2004-07-15 2008-08-27 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ， インコーポレイテッド ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
CN101547892B (zh) 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
WO2010132437A1 (en) 2009-05-12 2010-11-18 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用
CA2760837C (en) * 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
EP2611433A2 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
KR20150070249A (ko) 2012-10-09 2015-06-24 아레나 파마슈티칼스, 인크. 체중 관리 방법
WO2015153683A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
WO2021213353A1 (zh) * 2020-04-20 2021-10-28 苏州恩华生物医药科技有限公司 酰胺或者磺酰胺类衍生物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015639A (en) * 1987-03-27 1991-05-14 Schering Corporation Substituted benzazepines, their preparation and pharmaceutical compositions containing them
ZA882080B (en) * 1987-03-27 1989-04-26 Schering Corp Substituted benzazepines,their preparation and pharmaceutical compositions containing them
DE3936594A1 (de) * 1989-09-15 1991-03-28 Basf Ag (gamma)-glutamyl-transferasen zur behandlung von krankheiten
IL98487A0 (en) * 1990-06-15 1992-07-15 Schering Corp 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substituted benzazepines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU3722193A (en) 1993-09-13
ATE229510T1 (de) 2002-12-15
TW241260B (es) 1995-02-21
EP0628030A1 (en) 1994-12-14
WO1993016997A1 (en) 1993-09-02
CA2130797C (en) 2006-07-04
EP0628030B1 (en) 2002-12-11
JPH07504196A (ja) 1995-05-11
IL104828A0 (en) 1993-06-10
CA2130797A1 (en) 1993-08-26
IL104828A (en) 1999-08-17
DE69332559T2 (de) 2003-11-20
ZA931261B (en) 1993-08-23
US5241065A (en) 1993-08-31
DE69332559D1 (de) 2003-01-23
US5530125A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
ES2183810T3 (es) 2,3,4,5-tetrahidro-1h-3-benzacepinas que tienen actividad antipsicotica, y sintesis de arilacetamidas - alfa-sustituidas.
MY131574A (en) Method for producing catalysts consisting of metal of the platinum group by means of electroless deposition and the use thereof for the direct synthesis of hydrogen peroxide
Katritzky et al. The chemistry of benzotriazole. Part 8. A novel two-step procedure for the N-alkylation of amides
BG108089A (en) Pyridine matrix metalloproteinase inhibitors
ATE251608T1 (de) Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten
EP0776894A4 (en) OXAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND HERBICIDE
HUP0302960A2 (hu) Kemokinreceptorhoz kötődő heterociklusos vegyületek, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE120792T1 (de) Verwendung von c3- bis c5-polyfluoralkanen als treibgase.
GR3036017T3 (en) Heterocyclic fungicides
ES2150353A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
HUP0004664A2 (hu) Eljárás acilezett gyűrűs 1,3-dikarbonil-vegyületek előállítására
AU5932300A (en) Synthesis of zsm-5 and zsm-11
ATE482930T1 (de) Substituierte aromatische ringverbindungen, verfahren zu ihrer herstellung und ihre anwendung
ES2126890T3 (es) Preparacion de complejos de monociclopentadienilo con metales mediante sustitucion nucleofila de complejos de bis(ciclopentadienilo) con metales.
EP1043297A4 (en) PROCESS FOR THE PREPARATION OF COMPOUNDS HAVING -CH2-CHF- GROUPS
KR910005859A (ko) 항종양제
ES2171687T3 (es) Sintesis de base de piridina.
GB9526208D0 (en) Chemical compounds
BR9407271A (pt) Beta-aminovinilcetonas processo de preparação e utilização das mesmas
KR970065532A (ko) 고리형 n-비닐 카르복실산 아미드의 제조 방법
CA2141209A1 (en) Novel pyridyl- and pyrimidylpiperazine derivatives
KR930016394A (ko) 시클로알카논옥심의 열분해억제방법
EP0976731A4 (en) PROCESS FOR PRODUCING 5-METHYLINDOLINES
TW326043B (en) Method for preparing coumarin and derivatives thereof
ATE486847T1 (de) Bis(1-aziridino-1-hydroxyiminomethyl)-derivate, verfahren zu deren herstellung und deren verwendung als antitumormittel